Deferred Revenue

9 Months Ended

Sep. 30, 2011

Deferred Revenue [Abstract]

Deferred Revenue

NOTE 8 — DEFERRED REVENUE

Deferred revenue at September 30, 2011 and December 31, 2010 consisted of the following:

	September 30, 2011		December 31, 2010
	(in thousands)		(in thousands)
Current portion:
Deferred revenue from Astellas	$	23,747	$	23,138
Deferred revenue from Pfizer		36,015		36,015
Total	$	59,762	$	59,153
Long-term portion:
Deferred revenue from Astellas	$	53,432	$	69,477
Deferred revenue from Pfizer		45,018		72,030
Total	$	98,450	$	141,507